EP 1140838 A1 20011010 - 1, 4-PIPERAZINE DERIVATIVES HAVING 5HT1A RECEPTOR ACTIVITY
Title (en)
1, 4-PIPERAZINE DERIVATIVES HAVING 5HT1A RECEPTOR ACTIVITY
Title (de)
1, 4-PIPERAZINE DERIVATIVE MIT 5HT1A REZEPTOR AKTIVITÄT
Title (fr)
DERIVES DE 1,4-PIPERAZINE AGISSANT SUR LE RECEPTEUR DE 5HT1A
Publication
Application
Priority
- US 9929881 W 19991216
- US 21347098 A 19981217
Abstract (en)
[origin: WO0035878A1] Compounds of formula (A) are useful for the treatment of disorder of the central nervous system including anxiety, depression, panic, alcohol and drug addiction, sexual dysfunction, sleep disorders, cognitive disorders, Alzheimer's disease and Parkinson's disease.
IPC 1-7
IPC 8 full level
C07D 211/26 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); A61K 31/15 (2006.01); A61K 31/4525 (2006.01); A61K 31/496 (2006.01); A61P 3/04 (2006.01); A61P 15/10 (2006.01); A61P 25/00 (2006.01); A61P 25/06 (2006.01); A61P 25/16 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 25/32 (2006.01); A61P 43/00 (2006.01); C07D 211/56 (2006.01); C07D 211/58 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP)
A61P 3/04 (2017.12); A61P 15/10 (2017.12); A61P 25/00 (2017.12); A61P 25/06 (2017.12); A61P 25/16 (2017.12); A61P 25/20 (2017.12); A61P 25/22 (2017.12); A61P 25/24 (2017.12); A61P 25/28 (2017.12); A61P 25/30 (2017.12); A61P 25/32 (2017.12); A61P 43/00 (2017.12); C07D 211/56 (2013.01); C07D 211/58 (2013.01)
Citation (search report)
See references of WO 0035878A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0035878 A1 20000622; AU 3123100 A 20000703; BR 9916185 A 20010904; CA 2351859 A1 20000622; EP 1140838 A1 20011010; JP 2002532473 A 20021002
DOCDB simple family (application)
US 9929881 W 19991216; AU 3123100 A 19991216; BR 9916185 A 19991216; CA 2351859 A 19991216; EP 99965282 A 19991216; JP 2000588140 A 19991216